Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients With Colorectal or Breast Cancer
Status:
Completed
Trial end date:
2019-01-26
Target enrollment:
Participant gender:
Summary
A multicenter, randomized, open-label, three-period, and reference-replicated crossover study
was conducted in 48 patients with colorectal or breast cancer under fed conditions to assess
the bioequivalence between two formulations of capecitabine.